This course is designed for multidisciplinary team of head and neck cancer patients' health care providers, including medical oncologists and speech-language pathologists.
Renowned faculty members will demonstrate the most up-to-date information regarding head and neck cancer immunotherapy. Speech-language pathologists will learn novel diagnostic and therapeutic techniques to promote the highest functional outcomes.
11.25 AMA PRA Category 1 Credits™ - maximum
Back to All Events
Earlier Event: September 10
American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNSF) 2022 Annual Meeting & OTO Experience
Later Event: February 17
NASBS 32nd Annual Meeting